Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

• Main Authors: Mizrahi M (Author), Shabat Y (Author), Ben Ya'acov A (Author), Lalazar G (Author), Adar T (Author), Wong V (Author), Muller B (Author), Rawlin G (Author), Ilan Y (Author)
• Format: Book
• Published: Dove Medical Press, 2012-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Meir Mizrahi,1 Yehudit Shabat,1 Ami Ben Ya'acov,1 Gadi Lalazar,1 Tomer Adar,1 Victor Wong,2 Brian Muller,2 Grant Rawlin,2 Yaron Ilan11Liver Unit, Hebrew University-Hadassah Medical Center, Jerusalem, Israel; 2Immuron Limited, North Melbourne, AustraliaBackground: Nonalcoholic steatohepatitis...